Search Results - "Householder, Kyle T"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system by Cook, Rebecca L., Householder, Kyle T., Chung, Eugene P., Prakapenka, Alesia V., DiPerna, Danielle M., Sirianni, Rachael W.

    Published in Journal of controlled release (28-12-2015)
    “…In this work, we sought to test how surface modification of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with peptide ligand alters the brain specific…”
    Get full text
    Journal Article
  2. 2

    CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation by Moutal, Aubin, Villa, Lex Salas, Yeon, Seul Ki, Householder, Kyle T., Park, Ki Duk, Sirianni, Rachael W., Khanna, Rajesh

    Published in Molecular neurobiology (01-05-2018)
    “…Glioblastoma (GBM) is an aggressive primary brain tumor. The rapid growth and the privileged provenance of the tumor within the brain contribute to its…”
    Get full text
    Journal Article
  3. 3

    Curcumin-releasing mechanically adaptive intracortical implants improve the proximal neuronal density and blood–brain barrier stability by Potter, Kelsey A., Jorfi, Mehdi, Householder, Kyle T., Foster, E. Johan, Weder, Christoph, Capadona, Jeffrey R.

    Published in Acta biomaterialia (01-05-2014)
    “…[Display omitted] The cellular and molecular mechanisms by which neuroinflammatory pathways respond to and propagate the reactive tissue response to…”
    Get full text
    Journal Article
  4. 4

    Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma by Householder, Kyle T., DiPerna, Danielle M., Chung, Eugene P., Wohlleb, Gregory M., Dhruv, Harshil D., Berens, Michael E., Sirianni, Rachael W.

    Published in International journal of pharmaceutics (20-02-2015)
    “…[Display omitted] Effective treatment of glioblastoma multiforme remains a major clinical challenge, due in part to the difficulty of delivering…”
    Get full text
    Journal Article
  5. 5

    pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma by Householder, Kyle T., DiPerna, Danielle M., Chung, Eugene P., Luning, Anne Rosa, Nguyen, Duong T., Stabenfeldt, Sarah E., Mehta, Shwetal, Sirianni, Rachael W.

    Published in Colloids and surfaces, B, Biointerfaces (01-06-2018)
    “…[Display omitted] •Ionized quisinostat is loaded more efficiently onto PLA-PEG nanoparticles.•Quisinostat potency is maintained through nanoparticle…”
    Get full text
    Journal Article
  6. 6

    Abstract 1314: Evaluating payload delivery to the CNS from surface-modified nanoparticles by Householder, Kyle T., DiPerna, Danielle, Ghaffari, Layla, Sirianni, Rachael

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…The blood-brain barrier (BBB) remains a major obstacle to treatment of intracranial tumors. Most drugs are poorly bioavailable in the brain, and peripheral…”
    Get full text
    Journal Article
  7. 7

    Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo by Medina, David X., Householder, Kyle T., Ceton, Ricki, Kovalik, Tina, Heffernan, John M., Shankar, Rohini V., Bowser, Robert P., Wechsler-Reya, Robert J., Sirianni, Rachael W.

    Published in Journal of controlled release (10-05-2017)
    “…Understanding of the mechanisms by which systemically administered nanoparticles achieve delivery across biological barriers remains incomplete, due in part to…”
    Get full text
    Journal Article
  8. 8

    A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models by Potter-Baker, Kelsey A, Ravikumar, Madhumitha, Burke, Alan A, Meador, William D, Householder, Kyle T, Buck, Amy C, Sunil, Smrithi, Stewart, Wade G, Anna, Jake P, Tomaszewski, William H, Capadona, Jeffrey R

    Published in Biomaterials (01-07-2014)
    “…Abstract Rat models have emerged as a common tool to study neuroinflammation to intracortical microelectrodes. While a number of studies have attempted to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract B21: Use of polymeric nanoparticles for the delivery of YM155 to glioma cells in vitro and in vivo by Householder, Kyle T., DiPerna, Danielle M., Yamaguchi, Jonathan T., Sanai, Nader, Mehta, Shwetal, Sirianni, Rachael W.

    Published in Cancer research (Chicago, Ill.) (01-12-2015)
    “…YM155 (Sepantronium Bromide) is a potent survivin inhibitor that is the subject of clinical trials for multiple types of cancer including melanoma, lypmphoma,…”
    Get full text
    Journal Article
  11. 11

    Abstract 4579: Pathogen-derived targets for the delivery of chemotherapeutics to the brain by McCall, Rebecca L., Householder, Kyle T., Chung, Eugene P., Sirianni, Rachael W.

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Introduction The blood-brain barrier (BBB) is a key obstacle to achieving better treatment of glioblastoma multiforme (GBM). Tight junctions in the BBB prevent…”
    Get full text
    Journal Article
  12. 12

    Abstract 1329: Intravenous delivery of Erlotinib-loaded PLA-PEG nanoparticles for treatment of GB by Hartman, Lauren K., Dhruv, Harshil D., Householder, Kyle T., Roth, Jeffrey E., Schorzman, Allison N., Zamboni, William, Sirianni, Rachel, Berens, Michael E.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Amplification, overexpression, and mutation of the epidermal growth factor receptor (EGFR) gene represent common genetic signature abnormalities (>50%) in…”
    Get full text
    Journal Article